Spain is ranked as the
10th scientific power in the world, and
5th by scientific production in the EU 15.
For life sciences companies, Spain offers both
Governmental and infrastructure support.
The Spanish Government provides
low interest credits and incentives for companies during the
start-up and growth phase.
The region also has a
rapidly growing network of science and technology parks, research centres and institutes of technology, focused on driving innovation.
Spain is considered to be a
leader in personalised medicine and in the
development of innovative drugs for cancer, Alzheimers, autoimmune and infectious diseases.
With an
ageing population and a
push to increase Health Tourism, the
Spanish healthcare sector is expected to grow further, especially in the field of medical specialisation.
With the help of Biotechgate, a global Life Sciences database covering Biotechnology, Pharmaceuticals and the Medical Devices industry, we have put together an overview analysis of the Spanish Life Sciences industry in 2017
This analysis includes the key activities of life sciences companies, the number of products in development and a 5 year financing report…
View the Spanish Life Sciences Trend Analysis Here
Would you like to gain practical insights from industry experts on how to maximise the value of your Pharma and Biotech IP? Attend the Life Science IP Summit 2017 next October in Munich!
Tags: Biotech & Pharma spanish trends, biotech spain, IP analysis spain, life sciences spain
